Compagnie Lombard Odier SCmA’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.55K | Hold |
310
| – | – | ﹤0.01% | 395 |
|
|
2025
Q1 | $6.44K | Hold |
310
| – | – | ﹤0.01% | 436 |
|
|
2024
Q4 | $7.3K | Hold |
310
| – | – | ﹤0.01% | 412 |
|
|
2024
Q3 | $7.94K | Hold |
310
| – | – | ﹤0.01% | 408 |
|
|
2024
Q2 | $7.28K | Hold |
310
| – | – | ﹤0.01% | 401 |
|
|
2024
Q1 | $8.92K | Hold |
310
| – | – | ﹤0.01% | 430 |
|
|
2023
Q4 | $10.2K | Hold |
310
| – | – | ﹤0.01% | 490 |
|
|
2023
Q3 | $8.64K | Hold |
310
| – | – | ﹤0.01% | 521 |
|
|
2023
Q2 | $10.6K | Hold |
310
| – | – | ﹤0.01% | 500 |
|
|
2023
Q1 | $9.32K | Hold |
310
| – | – | ﹤0.01% | 556 |
|
|
2022
Q4 | $9K | Hold |
310
| – | – | ﹤0.01% | 610 |
|
|
2022
Q3 | $10K | Sell |
310
-1,434
| -82% | -$46.3K | ﹤0.01% | 566 |
|
|
2022
Q2 | $56K | Hold |
1,744
| – | – | ﹤0.01% | 424 |
|
|
2022
Q1 | $79K | Sell |
1,744
-1,003
| -37% | -$45.4K | ﹤0.01% | 399 |
|
|
2021
Q4 | $168K | Sell |
2,747
-445
| -14% | -$27.2K | ﹤0.01% | 387 |
|
|
2021
Q3 | $238K | Sell |
3,192
-1,000
| -24% | -$74.6K | 0.01% | 330 |
|
|
2021
Q2 | $389K | Sell |
4,192
-4,428
| -51% | -$411K | 0.01% | 262 |
|
|
2021
Q1 | $765K | Buy |
8,620
+6,420
| +292% | +$570K | 0.02% | 235 |
|
|
2020
Q4 | $205K | Buy |
2,200
+1,200
| +120% | +$112K | 0.01% | 325 |
|
|
2020
Q3 | $64K | Buy |
+1,000
| New | +$64K | ﹤0.01% | 361 |
|
|
2018
Q4 | – | Sell |
-1,500
| Closed | -$50K | – | 532 |
|
|
2018
Q3 | $50K | Buy |
+1,500
| New | +$50K | ﹤0.01% | 416 |
|